Kaplan-Meier estimation showed that ESCC patients with high METTL3 mRNA levels (greater than or equal to median) had shorter survival times than ESCC patients with low METTL3 mRNA levels (less than median) (Figure S2H). Here, METTL3 is linked to esophageal squamous cell carcinoma.